Unicycive Therapeutics Inc. Gains 30.1%
Fri, Mar 10, 2023 at 07:06 PM
Unicycive Therapeutics Inc. (UNCY:NASDAQ) shot up at $2.68, representing a gain of 30.1%. On Fri, Mar 10, 2023, UNCY:NASDAQ touched a New 2-Week High of $2.68. The stock got featured on our News Catalysts scanner on Mon, Mar 06, 2023 at 08:48 AM in the 'INVESTOR UPDATE' category. From Fri, Feb 24, 2023, the stock recorded 70.00% Up Days and 45.45% Green Days
About Unicycive Therapeutics Inc. (UNCY:NASDAQ)
Unicycive Therapeutics Inc is a biotechnology company dedicated towards developing treatments for certain medical conditions. It is focusing on kidney diseases.
Top 10 Gainers:
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 54.2%
- Cazoo Group Ltd Class A (CZOO:NYSE), 32.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 30.1%
- SportsMap Tech Acquisition Corp. (SMAP:NASDAQ), 29.83%
- Boxed Inc. (BOXD:NYSE), 26.89%
- Cingulate Inc. (CING:NASDAQ), 25%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 23.29%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 22.96%
- Solo Brands Inc. Class A (DTC:NYSE), 21.19%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 20.93%